Breakthrough zygomycosis and voriconazole [2] (multiple letters)

Journal of Infectious Diseases

Volumn 192, Issue 8, 2005, Pages 1496-1497

  Pagano, Livio ^a   Gleissner, Beate ^b   Fianchi, Luana ^a,c   Kontoyiannis, Dimitrios P ^d  

^a CATHOLIC UNIVERSITY   (Italy)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Istituto Mediterraneo di Ematologia   (Italy)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; VORICONAZOLE;

ANTIBIOTIC PROPHYLAXIS; ASPERGILLOSIS; DIABETES MELLITUS; DIAGNOSTIC TEST; DRUG UTILIZATION; HEMATOLOGIC MALIGNANCY; HIGH RISK PATIENT; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; INFECTION RISK; LETTER; MALNUTRITION; MUCORMYCOSIS; MULTIVARIATE ANALYSIS; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RISK FACTOR; ZYGOMYCETES;

ANTIFUNGAL AGENTS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; PYRIMIDINES; TRIAZOLES; ZYGOMYCOSIS;

EID: 25844482633     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/444433     Document Type: Letter

References (0)